Afanasjeva Janna
University of Illinois at Chicago, USA.
Hosp Pharm. 2017 Oct;52(9):645-649. doi: 10.1177/0018578717729663. Epub 2017 Sep 8.
Vitamin K, or phytonadione, is available in both injectable and oral formulations. Oral vitamin K is available as 5-mg tablets, but the key drawbacks for using vitamin K tablets consist of availability of only 1 dose strength and recent tripling of the product's cost over a 2-year period. An interest exists for utilization of injectable vitamin K via oral route. A literature search was performed on April 26, 2017, to identify any studies describing the use of injectable vitamin K for oral administration. The search involved PubMed and Embase and utilized various combinations of keywords , , , , , and . The results were limited to studies that discussed oral administration of injectable vitamin K. The efficacy of the injectable preparation of vitamin K administered orally was explored in 6 studies and one cost-savings project. Based on the available literature, the administration of injectable vitamin K via oral route is effective and safe. Injectable vitamin K for oral administration can be prepared as an undiluted solution or as a compounded solution. These 2 formulations have different beyond-use dates depending on ingredients used. Information on efficacy and stability of injectable vitamin K formulations prepared for oral administration provides an additional option for health care systems when vitamin K tablets are unavailable or cost-prohibitive to use.
维生素K,即叶绿醌,有注射剂和口服制剂两种形式。口服维生素K有5毫克片剂,但使用维生素K片剂的主要缺点包括只有一种剂量规格,且该产品成本在两年内上涨了两倍。人们对通过口服途径使用注射用维生素K存在兴趣。2017年4月26日进行了文献检索,以确定任何描述口服注射用维生素K的研究。检索涉及PubMed和Embase,并使用了各种关键词组合 , , , , ,和 。结果仅限于讨论口服注射用维生素K的研究。6项研究和一个成本节约项目探讨了口服注射用维生素K制剂的疗效。根据现有文献,通过口服途径给药的注射用维生素K是有效且安全的。口服注射用维生素K可制备成未稀释溶液或复合溶液。这两种制剂根据所用成分有不同的使用期限。当无法获得维生素K片剂或使用成本过高时,关于口服注射用维生素K制剂的疗效和稳定性信息为医疗保健系统提供了另一种选择。